Anterior hippocampus in schizophrenia pathogenesis: molecular evidence from a proteome study

References

• Harrison PJ, Eastwood SL. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 2001; 11: 508–519
   PubMed Web of Science ®Google Scholar
• Lawrie SM, Whalley H, Kestelman JN, et al. Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet 1999; 353: 30–33
   PubMed Web of Science ®Google Scholar
• Antonova E, Sharma T, Morris R, Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 2004; 70: 117–145
   PubMed Web of Science ®Google Scholar
• Szeszko PR, Goldberg E, Gunduz-Bruce H, et al. Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. Am J Psychiatry 2003; 160: 2190–2197
   PubMed Web of Science ®Google Scholar
• Goldman MB, Mitchell CP. What is the functional significance of hippocampal pathology in schizophrenia?. Schizophr Bull 2004; 30: 367–392
   PubMed Web of Science ®Google Scholar
• Harrison PJ. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 2004; 174: 151–162
   PubMed Web of Science ®Google Scholar
• Harrison PJ, Eastwood SL. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 1998; 352: 1669–1673
   PubMed Web of Science ®Google Scholar
• Eastwood SL, Harrison PJ. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69: 339–343
   PubMed Web of Science ®Google Scholar
• Rosoklija G, Toomayan G, Ellis SP, et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000; 57: 349–356
   PubMed Web of Science ®Google Scholar
• Kerwin R, Patel S, Meldrum B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 1990; 39: 25–32
   PubMed Web of Science ®Google Scholar
• Deakin JF, Slater P, Simpson MD, et al. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 1989; 52: 1781–1786
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Reynolds GP. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 2002; 55: 1–10
   PubMed Web of Science ®Google Scholar
• Scarr E, Pavey G, Copolov D, Dean B. Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects. Schizophr Res 2004; 71: 383–392
   PubMed Web of Science ®Google Scholar
• Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B. Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation. Biol Psychiatry 2000; 48: 381–388
   PubMed Web of Science ®Google Scholar
• Tamminga CA, Thaker GK, Buchanan R, et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49: 522–530
   PubMed Web of Science ®Google Scholar
• Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 2005; 10: 27–39
   PubMed Web of Science ®Google Scholar
• Tamminga CA, Vogel M, Gao X, Lahti AC, Holcomb HH. The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Res Brain Res Rev 2000; 31: 364–370
   PubMedGoogle Scholar
• Katsel P, Davis KL, Gorman JM, Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr Res 2005; 77: 241–252
   PubMed Web of Science ®Google Scholar
• Edgar PF, Schonberger SJ, Dean B, Faull RL, Kydd R, Cooper GJ. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol Psychiatry 1999; 4: 173–178
   PubMed Web of Science ®Google Scholar
• American P. Diagnostic and statistical manual of mental disorders4th edn. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Sivagnanasundaram S, Crossett B, Dedova I, Cordwell S, Matsumoto I. Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study. Proteomics Clin App 2007; 1: 1291–1305
   PubMed Web of Science ®Google Scholar
• Miller I, Crawford J, Gianazza E. Protein stains for proteomic applications: which, when, why?. Proteomics 2006; 6: 5385–5408
   PubMed Web of Science ®Google Scholar
• Karp NA, Spencer M, Lindsay H, O'Dell K, Lilley KS. Impact of replicate types on proteomic expression analysis. J Proteome Res 2005; 4: 1867–1871
   PubMed Web of Science ®Google Scholar
• Clark D, Dedova I, Cordwell S, Matsumoto I. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol Psychiatry 2006; 11: 459–470,423
   PubMed Web of Science ®Google Scholar
• Fountoulakis M. Application of proteomics technologies in the investigation of the brain. Mass Spectrom Rev 2004; 23: 231–258
   PubMed Web of Science ®Google Scholar
• Burbaeva G, Savushkina OK, Boksha IS. Creatine kinase BB in brain in schizophrenia. World J Biol Psychiatry 2003; 4: 177–183
   PubMed Web of Science ®Google Scholar
• Aksenova MV, Karaseva NS, Burbaeva G. Creatine phosphokinase distribution in the brain in schizophrenia and Alzheimer's disease]. Zh Nevropatol Psikhiatr Im S S Korsakova 1993; 93: 35–36
   Google Scholar
• Altar CA, Jurata LW, Charles V, et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005; 58: 85–96
   PubMed Web of Science ®Google Scholar
• Bernstein HG, Braunewell KH, Spilker C, et al. Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia. Neuroreport 2002; 13: 393–396
   PubMed Web of Science ®Google Scholar
• Akyol O, Yanik M, Elyas H, et al. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 123–131
   PubMed Web of Science ®Google Scholar
• Pae CU, Kim TS, Kwon OJ, et al. Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia. Neurosci Res 2005; 53: 8–13
   PubMed Web of Science ®Google Scholar
• Jia Y, Yu X, Zhang B, et al. An association study between polymorphisms in three genes of 14-3-3 (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein) family and paranoid schizophrenia in northern Chinese population. Eur Psychiatry 2004; 19: 377–379
   PubMed Web of Science ®Google Scholar
• Tamminga CA, Lahti AC, Medoff DR, Gao XM, Holcomb HH. Evaluating glutamatergic transmission in schizophrenia. Ann N Y Acad Sci 2003; 1003: 113–118
   PubMed Web of Science ®Google Scholar
• Harrison PJ, Law AJ, Eastwood SL. Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann N Y Acad Sci 2003; 1003: 94–101
   PubMed Web of Science ®Google Scholar
• Costa E, Davis JM, Dong E, et al. A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 2004; 16: 1–23
   PubMedGoogle Scholar
• Morel N. Neurotransmitter release: the dark side of the vacuolar-H + ATPase. Biol Cell 2003; 95: 453–457
   PubMed Web of Science ®Google Scholar
• Gotow T, Sakata M, Funakoshi T, Uchiyama Y. Preferential localization of annexin V to the axon terminal. Neuroscience 1996; 75: 507–521
   PubMed Web of Science ®Google Scholar
• Couve A, Kittler JT, Uren JM, et al. Association of GABA(B) receptors and members of the 14-3-3 family of signaling proteins. Mol Cell Neurosci 2001; 17: 317–328
   PubMed Web of Science ®Google Scholar
• Hubbard KB, Hepler JR. Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins. Cell Signal 2006; 18: 135–150
   PubMed Web of Science ®Google Scholar
• Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10:40–68; image 45.
   PubMed Web of Science ®Google Scholar
• Brackmann M, Schuchmann S, Anand R, Braunewell KH. Neuronal Ca2+ sensor protein VILIP-1 affects cGMP signalling of guanylyl cyclase B by regulating clathrin-dependent receptor recycling in hippocampal neurons. J Cell Sci 2005; 118: 2495–2505
   PubMed Web of Science ®Google Scholar
• Lin L, Jeanclos EM, Treuil M, Braunewell KH, Gundelfinger ED, Anand R. The calcium sensor protein visinin-like protein-1 modulates the surface expression and agonist sensitivity of the alpha 4beta 2 nicotinic acetylcholine receptor. J Biol Chem 2002; 277: 41 872–41 878
   Web of Science ®Google Scholar
• Spilker C, Gundelfinger ED, Braunewell KH. Evidence for different functional properties of the neuronal calcium sensor proteins VILIP-1 and VILIP-3: from subcellular localization to cellular function. Biochim Biophys Acta 2002; 1600: 118–127
   PubMed Web of Science ®Google Scholar
• Potkin SG, Alva G, Fleming K, et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry 2002; 159: 227–237
   PubMed Web of Science ®Google Scholar
• Ben-Shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 2002; 83: 1241–1251
   PubMed Web of Science ®Google Scholar
• Smeitink J, van den Heuvel L. Human mitochondrial complex I in health and disease. Am J Hum Genet 1999; 64: 1505–1510
   PubMed Web of Science ®Google Scholar
• Lariviere RC, Julien JP. Functions of intermediate filaments in neuronal development and disease. J Neurobiol 2004; 58: 131–148
   PubMed Web of Science ®Google Scholar
• Matus A. Actin-based plasticity in dendritic spines. Science 2000; 290: 754–758
   PubMed Web of Science ®Google Scholar
• dos Remedios CG, Chhabra D, Kekic M, et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 2003; 83: 433–473
   PubMed Web of Science ®Google Scholar
• Leffers H, Nielsen MS, Andersen AH, et al. Identification of two human Rho GDP dissociation inhibitor proteins whose overexpression leads to disruption of the actin cytoskeleton. Exp Cell Res 1993; 209: 165–174
   PubMed Web of Science ®Google Scholar
• Curmi PA, Gavet O, Charbaut E, et al. Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct Funct 1999; 24: 345–357
   PubMed Web of Science ®Google Scholar
• Satoh J, Yamamura T, Arima K. The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes. Am J Pathol 2004; 165: 577–592
   PubMed Web of Science ®Google Scholar
• Li H, Guo Y, Teng J, Ding M, Yu AC, Chen J. 14-3-3gamma affects dynamics and integrity of glial filaments by binding to phosphorylated GFAP. J Cell Sci 2006; 119: 4452–4461
   PubMed Web of Science ®Google Scholar
• Matthews TA, Johnson GV. 14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture models. Neurosci Lett 2005; 384: 211–216
   PubMed Web of Science ®Google Scholar
• Ge WW, Volkening K, Leystra-Lantz C, Jaffe H, Strong MJ. 14-3-3 protein binds to the low molecular weight neurofilament (NFL) mRNA 3′ UTR. Mol Cell Neurosci 2007; 34: 80–87
   PubMed Web of Science ®Google Scholar
• Tanaka J, Sobue K. Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J Neurosci 1994; 14: 1038–1052
   PubMed Web of Science ®Google Scholar
• Laferriere NB, MacRae TH, Brown DL. Tubulin synthesis and assembly in differentiating neurons. Biochem Cell Biol 1997; 75: 103–117
   PubMed Web of Science ®Google Scholar
• Lewis SA, Tian G, Vainberg IE, Cowan NJ. Chaperonin-mediated folding of actin and tubulin. J Cell Biol 1996; 132: 1–4
   PubMed Web of Science ®Google Scholar
• Arnold SE, Lee VM, Gur RE, Trojanowski JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci U S A 1991; 88: 10 850–10 854
   Web of Science ®Google Scholar
• Benes FM, Sorensen I, Bird ED. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991; 17: 597–608
   PubMed Web of Science ®Google Scholar
• Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122(Pt 4)593–624
   PubMed Web of Science ®Google Scholar
• Arnold SE, Franz BR, Gur RC, et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 1995; 152: 738–748
   PubMed Web of Science ®Google Scholar
• Clark D, Dedova I, Cordwell S, Matsumoto I. Altered proteins of the anterior cingulate cortex white matter proteome in schizophrenia. Proteomics Clin App 2007; 1: 157–166
   PubMed Web of Science ®Google Scholar
• Novikova SI, He F, Cutrufello NJ, Lidow MS. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Neurobiol Dis 2006; 23: 61–76
   PubMed Web of Science ®Google Scholar
• Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 2006; 6: 3414–3425
   PubMed Web of Science ®Google Scholar
• Prabakaran S, Swatton JE, Ryan MM, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684–697, 643
   PubMed Web of Science ®Google Scholar
• Pennington K, Beasley CL, Dicker P, et al. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry 2008; 13: 1102–1117
   PubMed Web of Science ®Google Scholar
• Stephan KE, Baldeweg T, Friston KJ. Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 2006; 59: 929–939
   PubMed Web of Science ®Google Scholar